92 related articles for article (PubMed ID: 16729120)
1. The synthesis of tethered ligand dimers for PPARgamma-RXR protein heterodimers.
Mohler DL; Shen G
Org Biomol Chem; 2006 Jun; 4(11):2082-7. PubMed ID: 16729120
[TBL] [Abstract][Full Text] [Related]
2. A naturally occurring rexinoid, honokiol, can serve as a regulator of various retinoid x receptor heterodimers.
Kotani H; Tanabe H; Mizukami H; Amagaya S; Inoue M
Biol Pharm Bull; 2012; 35(1):1-9. PubMed ID: 22223330
[TBL] [Abstract][Full Text] [Related]
3. Differentiation and growth inhibition mediated via the RXR:PPARgamma heterodimer in colon cancer.
Cesario RM; Stone J; Yen WC; Bissonnette RP; Lamph WW
Cancer Lett; 2006 Aug; 240(2):225-33. PubMed ID: 16271436
[TBL] [Abstract][Full Text] [Related]
4. Structure-based de novo design, synthesis, and biological evaluation of the indole-based PPARgamma ligands (I).
Dong X; Zhang Z; Wen R; Shen J; Shen X; Jiang H
Bioorg Med Chem Lett; 2006 Nov; 16(22):5913-6. PubMed ID: 17010604
[TBL] [Abstract][Full Text] [Related]
5. Retinoid X receptor and peroxisome proliferator-activated receptor-gamma agonists cooperate to inhibit matrix metalloproteinase gene expression.
Burrage PS; Schmucker AC; Ren Y; Sporn MB; Brinckerhoff CE
Arthritis Res Ther; 2008; 10(6):R139. PubMed ID: 19046432
[TBL] [Abstract][Full Text] [Related]
6. Modulation of RXR function through ligand design.
Pérez E; Bourguet W; Gronemeyer H; de Lera AR
Biochim Biophys Acta; 2012 Jan; 1821(1):57-69. PubMed ID: 21515403
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of benzofused heterocyclic RXR modulators.
Gernert DL; Neel DA; Boehm MF; Leibowitz MD; Mais DA; Michellys PY; Rungta D; Reifel-Miller A; Grese TA
Bioorg Med Chem Lett; 2004 Jun; 14(11):2759-63. PubMed ID: 15125928
[TBL] [Abstract][Full Text] [Related]
8. Ligand Activity of Group 15 Compounds Possessing Triphenyl Substituent for the RXR and PPARγ Nuclear Receptors.
Hiromori Y; Ido A; Aoki A; Kimura T; Nagase H; Nakanishi T
Biol Pharm Bull; 2016; 39(10):1596-1603. PubMed ID: 27725436
[TBL] [Abstract][Full Text] [Related]
9. Antagonist-perturbation mechanism for activation function-2 fixed motifs: active conformation and docking mode of retinoid X receptor antagonists.
Tsuji M
J Comput Aided Mol Des; 2017 Jun; 31(6):577-585. PubMed ID: 28534193
[TBL] [Abstract][Full Text] [Related]
10. Manipulation of reciprocal salt bridges at the heterodimerization interface alters the dimerization properties of mouse RXRalpha and PPARgamma1.
Chan LS; Wells RA
Biochem Biophys Res Commun; 2007 Jul; 358(4):1080-5. PubMed ID: 17521607
[TBL] [Abstract][Full Text] [Related]
11. Enhanced effects of PPARgamma ligands and RXR selective retinoids in combination to inhibit migration and invasiveness in cancer cells.
Papi A; Rocchi P; Ferreri AM; Guerra F; Orlandi M
Oncol Rep; 2009 Apr; 21(4):1083-9. PubMed ID: 19288012
[TBL] [Abstract][Full Text] [Related]
12. Effects of PPAR and RXR ligands in semaphorin 6B gene expression of human MCF-7 breast cancer cells.
Murad H; Collet P; Huin-Schohn C; Al-Makdissy N; Kerjan G; Chedotal A; Donner M; Devignes MD; Becuwe P; Schohn H; Domenjoud L; Dauça M
Int J Oncol; 2006 Apr; 28(4):977-84. PubMed ID: 16525649
[TBL] [Abstract][Full Text] [Related]
13. [Advances in studies on selective RXR ligands].
Mei JH; Wang MW
Yao Xue Xue Bao; 2005 Apr; 40(4):294-8. PubMed ID: 16011254
[No Abstract] [Full Text] [Related]
14. Corepressor interaction differentiates the permissive and non-permissive retinoid X receptor heterodimers.
Lammi J; Perlmann T; Aarnisalo P
Arch Biochem Biophys; 2008 Apr; 472(2):105-14. PubMed ID: 18282463
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide profiling of PPARgamma:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis.
Nielsen R; Pedersen TA; Hagenbeek D; Moulos P; Siersbaek R; Megens E; Denissov S; Børgesen M; Francoijs KJ; Mandrup S; Stunnenberg HG
Genes Dev; 2008 Nov; 22(21):2953-67. PubMed ID: 18981474
[TBL] [Abstract][Full Text] [Related]
16. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
Lin MS; Chen WC; Bai X; Wang YD
J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
[TBL] [Abstract][Full Text] [Related]
17. Combined low doses of PPARgamma and RXR ligands trigger an intrinsic apoptotic pathway in human breast cancer cells.
Bonofiglio D; Cione E; Qi H; Pingitore A; Perri M; Catalano S; Vizza D; Panno ML; Genchi G; Fuqua SA; Andò S
Am J Pathol; 2009 Sep; 175(3):1270-80. PubMed ID: 19644018
[TBL] [Abstract][Full Text] [Related]
18. Design and structural analysis of novel pharmacophores for potent and selective peroxisome proliferator-activated receptor gamma agonists.
Lin CH; Peng YH; Coumar MS; Chittimalla SK; Liao CC; Lyn PC; Huang CC; Lien TW; Lin WH; Hsu JT; Cheng JH; Chen X; Wu JS; Chao YS; Lee HJ; Juo CG; Wu SY; Hsieh HP
J Med Chem; 2009 Apr; 52(8):2618-22. PubMed ID: 19301897
[TBL] [Abstract][Full Text] [Related]
19. Growth factor-antagonized rexinoid apoptosis involves permissive PPARgamma/RXR heterodimers to activate the intrinsic death pathway by NO.
Shankaranarayanan P; Rossin A; Khanwalkar H; Alvarez S; Alvarez R; Jacobson A; Nebbioso A; de Lera AR; Altucci L; Gronemeyer H
Cancer Cell; 2009 Sep; 16(3):220-31. PubMed ID: 19732722
[TBL] [Abstract][Full Text] [Related]
20. Atomic structure of mutant PPARgamma LBD complexed with 15d-PGJ2: novel modulation mechanism of PPARgamma/RXRalpha function by covalently bound ligands.
Waku T; Shiraki T; Oyama T; Morikawa K
FEBS Lett; 2009 Jan; 583(2):320-4. PubMed ID: 19101554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
